Etilefrine hydrochloride
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 592558

CAS#: 943-17-9 (HCl)

Description: Etilefrine hydrochloride is an adrenergic agonist that appears to interact with beta-2 and some alpha adrenergic receptors. It has been used as a vasoconstrictor agent.


Chemical Structure

img
Etilefrine hydrochloride
CAS# 943-17-9 (HCl)

Theoretical Analysis

MedKoo Cat#: 592558
Name: Etilefrine hydrochloride
CAS#: 943-17-9 (HCl)
Chemical Formula: C10H16ClNO2
Exact Mass: 217.09
Molecular Weight: 0.000
Elemental Analysis: C, 55.17; H, 7.41; Cl, 16.28; N, 6.43; O, 14.70

Price and Availability

Size Price Availability Quantity
1g USD 285 2 Weeks
5g USD 585 2 Weeks
Bulk inquiry

Related CAS #: 943-17-9 (HCl)   709-55-7 (free base)   95670-87-4 (S-isomer HCl)   95670-88-5 (R-isomer HCl)    

Synonym: Etilefrine hydrochloride; Ethyl adrianol

IUPAC/Chemical Name: alpha-((Ethylamino)methyl)-m-hydroxybenzyl alcohol hydrochloride

InChi Key: KTNROWWHOBZQGK-UHFFFAOYSA-N

InChi Code: InChI=1S/C10H15NO2.ClH/c1-2-11-7-10(13)8-4-3-5-9(12)6-8;/h3-6,10-13H,2,7H2,1H3;1H

SMILES Code: OC1=CC(C(O)CNCC)=CC=C1.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 0.00 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Muniz G, Hidalgo-Campos J, Valdivia-Tapia MDC, Shaikh N, Carreazo NY. Successful Management of Chylothorax With Etilefrine: Case Report in 2 Pediatric Patients. Pediatrics. 2018 May;141(5). pii: e20163309. doi: 10.1542/peds.2016-3309. PubMed PMID: 29703801.

2: Koga C, Murakami M, Shimizu J, Yasuyama A, Matsumura T, Takata A, Kameda C, Kawabata R, Hirota M, Noura S, Hasegawa J. [A Case of Successful Management of Postoperative Chylous Ascites by Combination Therapy with Octreotide and Etilefrine]. Gan To Kagaku Ryoho. 2018 Mar;45(3):572-574. Japanese. PubMed PMID: 29650942.

3: Bhardwaj R, Vaziri H, Gautam A, Ballesteros E, Karimeddini D, Wu GY. Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment. J Clin Transl Hepatol. 2018 Mar 28;6(1):105-113. doi: 10.14218/JCTH.2017.00035. Epub 2017 Dec 4. Review. PubMed PMID: 29577037; PubMed Central PMCID: PMC5863006.

4: Rimayi C, Odusanya D, Weiss JM, de Boer J, Chimuka L. Contaminants of emerging concern in the Hartbeespoort Dam catchment and the uMngeni River estuary 2016 pollution incident, South Africa. Sci Total Environ. 2018 Jun 15;627:1008-1017. doi: 10.1016/j.scitotenv.2018.01.263. Epub 2018 Feb 3. PubMed PMID: 29426120.

5: Ohkura Y, Ueno M, Iizuka T, Udagawa H. Effectiveness of etilefrine regimen for chylothorax after esophagectomy with thoracic duct resection. Esophagus. 2018;15(1):33-38. doi: 10.1007/s10388-017-0592-6. Epub 2017 Sep 14. PubMed PMID: 29308064; PubMed Central PMCID: PMC5742336.

6: Zilker M, Sörgel F, Holzgrabe U. A stability-study of expired ampoules manufactured more than 40 years ago. J Pharm Biomed Anal. 2018 Feb 20;150:318-326. doi: 10.1016/j.jpba.2017.12.019. Epub 2017 Dec 13. PubMed PMID: 29274583.

7: Omar MA, Badr El-Din KM, Salem H, Abdelmageed OH. Novel kinetic spectrophotometric method for estimation of certain biologically active phenolic sympathomimetic drugs in their bulk powders and different pharmaceutical formulations. Spectrochim Acta A Mol Biomol Spectrosc. 2018 Mar 15;193:310-317. doi: 10.1016/j.saa.2017.12.045. Epub 2017 Dec 14. PubMed PMID: 29258026.

8: Omar MA, Badr El-Din KM, Salem H, Abdelmageed OH. Spectrophotometric and spectrofluorimetric methods for determination of certain biologically active phenolic drugs in their bulk powders and different pharmaceutical formulations. Spectrochim Acta A Mol Biomol Spectrosc. 2018 Mar 5;192:108-116. doi: 10.1016/j.saa.2017.10.065. Epub 2017 Nov 8. PubMed PMID: 29127827.

9: Chinegwundoh FI, Smith S, Anie KA. Treatments for priapism in boys and men with sickle cell disease. Cochrane Database Syst Rev. 2017 Sep 19;9:CD004198. doi: 10.1002/14651858.CD004198.pub3. Review. PubMed PMID: 28926088.

10: Tamura T, Kubo N, Yamamoto A, Sakurai K, Toyokawa T, Tanaka H, Muguruma K, Yashiro M, Maeda K, Hirakawa K, Ohira M. Cervical chylous leakage following esophagectomy that was successfully treated by intranodal lipiodol lymphangiography: a case report. BMC Surg. 2017 Feb 28;17(1):20. doi: 10.1186/s12893-017-0218-x. PubMed PMID: 28245822; PubMed Central PMCID: PMC5331703.

11: Badr El-Din KM, Attia TZ. Spectrofluorimetric determination of certain adrenergic agonist drugs in their pure forms and pharmaceutical formulations: Content uniformity test application. Luminescence. 2017 Aug;32(5):706-712. doi: 10.1002/bio.3240. Epub 2016 Nov 29. PubMed PMID: 27900836.

12: Konishi T, Funayama N, Yamamoto T, Nishihara H, Hotta D, Kikuchi K, Yokoyama H, Ohori K. Intraprocedural left ventricular free wall rupture diagnosed by left ventriculogram in a patient with infero-posterior myocardial infarction and severe aortic stenosis. BMC Cardiovasc Disord. 2016 Jun 6;16:126. doi: 10.1186/s12872-016-0302-7. PubMed PMID: 27266264; PubMed Central PMCID: PMC4895822.

13: Ohkura Y, Ueno M, Iizuka T, Haruta S, Tanaka T, Udagawa H. New Combined Medical Treatment With Etilefrine and Octreotide for Chylothorax After Esophagectomy: A Case Report and Review of the Literature. Medicine (Baltimore). 2015 Dec;94(49):e2214. doi: 10.1097/MD.0000000000002214. PubMed PMID: 26656358; PubMed Central PMCID: PMC5008503.

14: Oh H, Li T, An J. Drug Release Properties of a Series of Adenine-Based Metal-Organic Frameworks. Chemistry. 2015 Nov 16;21(47):17010-5. doi: 10.1002/chem.201501560. Epub 2015 Sep 25. PubMed PMID: 26403522.

15: Drugs for hypotension: disproportionate harms with etilefrine and heptaminol. . Prescrire Int. 2015 Jul;24(162):184. PubMed PMID: 26240886.

16: Kremer JJ, Bills AJ, Hanke NJ, Chen H, Meier WA, Osinski MA, Foley CM. Evaluation of cardiovascular changes in dogs administered three positive controls using jacketed external telemetry-blood pressure (JET-BP). J Pharmacol Toxicol Methods. 2015 Sep-Oct;75:27-37. doi: 10.1016/j.vascn.2015.05.008. Epub 2015 May 20. PubMed PMID: 26001324.

17: Hara R, Nagai A, Fujii T, Fukumoto K, Ohira S, Jo Y, Yokoyama T, Miyaji Y. Practical application of color Doppler ultrasonography in patients with ejaculatory dysfunction. Int J Urol. 2015 Jun;22(6):609-11. doi: 10.1111/iju.12754. Epub 2015 Mar 22. PubMed PMID: 25808696.

18: Bender B, Murthy V, Chamberlain RS. The changing management of chylothorax in the modern era. Eur J Cardiothorac Surg. 2016 Jan;49(1):18-24. doi: 10.1093/ejcts/ezv041. Epub 2015 Mar 1. Review. PubMed PMID: 25732972.

19: Zabrzewska B, Chyła A, Bogdan A. Development studies on determination of preservatives decomposition products. Acta Pol Pharm. 2014 Jul-Aug;71(4):563-73. PubMed PMID: 25272883.

20: Niehoff MO, Niggemann B, Sternberg J, Jenkins A, Holbrook M. Measurement of hyper- and hypotension during repeated dose toxicity studies in either freely moving or physically restrained cynomolgus monkeys. J Pharmacol Toxicol Methods. 2014 Nov-Dec;70(3):268-75. doi: 10.1016/j.vascn.2014.09.004. Epub 2014 Sep 16. PubMed PMID: 25219539.